Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1988 May;43(5):349–353. doi: 10.1136/thx.43.5.349

Control of nocturnal hypoventilation by nasal intermittent positive pressure ventilation.

N Carroll 1, M A Branthwaite 1
PMCID: PMC461243  PMID: 3143160

Abstract

Ten patients with respiratory failure and nocturnal hypoventilation were treated for three to nine months by nasal intermittent positive pressure ventilation. Four patients had chronic obstructive lung disease (median FEV1 19% predicted) and six restrictive chest wall disorders (median FVC 25% predicted); eight of the patients also had cardiac failure. The median daytime arterial oxygen tension, measured before and after at least three months' treatment, increased from 6.2 (range 5.4-9.6) to 9.1 (7.1-9.8) kPa in those with restrictive disease (p less than 0.05), and from 6.0 (5.7-6.5) to 7.1 (6.3-7.7) kPa in the four with airflow limitation (NS). Median values for arterial carbon dioxide tension over the same time fell from 8.2 (range 6.7-9.8) to 6.5 (6.0-6.9) kPa in the group with restrictive disease (p less than 0.05) and from 8.2 (7.0-9.2) to 7.1 (4.9-7.7) kPa in those with airflow limitation (p less than 0.02). Total sleep time while patients were using nasal positive pressure ventilation varied from 155 to 379 (median 341) minutes, and included 4-26% rapid eye movement sleep (median 14%). The percentage of monitored time during the night in which the arterial oxygen saturation was less than 80% fell from a median (range) of 96 (3-100) to 4 (0-9) in the six patients with restrictive disease and from 100 (98-100) to 40 (2-51) in those with airflow limitation. There were no changes in spirometric values but exercise tolerance improved in all patients. The technique may prove an acceptable alternative to long term domiciliary oxygen therapy in selected patients.

Full text

PDF
349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calverley P. M., Brezinova V., Douglas N. J., Catterall J. R., Flenley D. C. The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis. 1982 Aug;126(2):206–210. doi: 10.1164/arrd.1982.126.2.206. [DOI] [PubMed] [Google Scholar]
  2. Catterall J. R., Douglas N. J., Calverley P. M., Shapiro C. M., Brezinova V., Brash H. M., Flenley D. C. Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome. Am Rev Respir Dis. 1983 Jul;128(1):24–29. doi: 10.1164/arrd.1983.128.1.24. [DOI] [PubMed] [Google Scholar]
  3. Cooper C. B., Waterhouse J., Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax. 1987 Feb;42(2):105–110. doi: 10.1136/thx.42.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davis J. N., Loh L. Alveolar hypoventilation and respiratory muscle weakness. Bull Eur Physiopathol Respir. 1979;15 (Suppl):45–53. [PubMed] [Google Scholar]
  5. Ellis E. R., Bye P. T., Bruderer J. W., Sullivan C. E. Treatment of respiratory failure during sleep in patients with neuromuscular disease. Positive-pressure ventilation through a nose mask. Am Rev Respir Dis. 1987 Jan;135(1):148–152. doi: 10.1164/arrd.1987.135.1.148. [DOI] [PubMed] [Google Scholar]
  6. Fleetham J., West P., Mezon B., Conway W., Roth T., Kryger M. Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. Am Rev Respir Dis. 1982 Sep;126(3):429–433. doi: 10.1164/arrd.1982.126.3.429. [DOI] [PubMed] [Google Scholar]
  7. Goldstein R. S., Ramcharan V., Bowes G., McNicholas W. T., Bradley D., Phillipson E. A. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med. 1984 Feb 16;310(7):425–429. doi: 10.1056/NEJM198402163100704. [DOI] [PubMed] [Google Scholar]
  8. Guilleminault C., Kurland G., Winkle R., Miles L. E. Severe kyphoscoliosis, breathing, and sleep: the "Quasimodo" syndrome during sleep. Chest. 1981 Jun;79(6):626–630. doi: 10.1378/chest.79.6.626. [DOI] [PubMed] [Google Scholar]
  9. Hoeppner V. H., Cockcroft D. W., Dosman J. A., Cotton D. J. Nighttime ventilation improves respiratory failure in secondary kyphoscoliosis. Am Rev Respir Dis. 1984 Feb;129(2):240–243. [PubMed] [Google Scholar]
  10. Kerby G. R., Mayer L. S., Pingleton S. K. Nocturnal positive pressure ventilation via nasal mask. Am Rev Respir Dis. 1987 Mar;135(3):738–740. doi: 10.1164/arrd.1987.135.3.738. [DOI] [PubMed] [Google Scholar]
  11. Longobardo G. S., Gothe B., Goldman M. D., Cherniack N. S. Sleep apnea considered as a control system instability. Respir Physiol. 1982 Dec;50(3):311–333. doi: 10.1016/0034-5687(82)90026-3. [DOI] [PubMed] [Google Scholar]
  12. Rochester D. F., Braun N. M., Laine S. Diaphragmatic energy expenditure in chronic respiratory failure. The effect of assisted ventilation with body respirators. Am J Med. 1977 Aug;63(2):223–232. doi: 10.1016/0002-9343(77)90236-4. [DOI] [PubMed] [Google Scholar]
  13. Sawicka E. H., Loh L., Branthwaite M. A. Domiciliary ventilatory support: an analysis of outcome. Thorax. 1988 Jan;43(1):31–35. doi: 10.1136/thx.43.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Simonds A. K., Parker R. A., Branthwaite M. A. Effects of protriptyline on sleep related disturbances of breathing in restrictive chest wall disease. Thorax. 1986 Aug;41(8):586–590. doi: 10.1136/thx.41.8.586. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES